241 related articles for article (PubMed ID: 30335057)
1. [Comparative morphological characteristics and immunophenotype of urothelial carcinomas of the renal pelvis and bladder].
Osmanov YI; Gaibov ZA; Kogan EA; Radenska-Lopovok SG; Tursunov KZ
Arkh Patol; 2018; 80(5):23-32. PubMed ID: 30335057
[TBL] [Abstract][Full Text] [Related]
2. [Morphological and immunohistochemical characteristics of the molecular subtypes of urothelial carcinomas].
Osmanov YI; Gaibov ZA; Kogan EA; Radenska-Lopovok SG; Tursunov KZ
Arkh Patol; 2019; 81(5):35-44. PubMed ID: 31626203
[TBL] [Abstract][Full Text] [Related]
3. High-grade urothelial carcinoma of the renal pelvis: clinicopathologic study of 108 cases with emphasis on unusual morphologic variants.
Perez-Montiel D; Wakely PE; Hes O; Michal M; Suster S
Mod Pathol; 2006 Apr; 19(4):494-503. PubMed ID: 16474378
[TBL] [Abstract][Full Text] [Related]
4. Protein gene product 9.5 is diagnostically helpful in delineating high-grade renal cell cancer involving the renal medullary/sinus region from invasive urothelial cell carcinoma of the renal pelvis.
Gunia S; Erbersdobler A; Koch S; Otto W; Staibano S; D'Alterio C; Brookman-May S
Hum Pathol; 2013 May; 44(5):712-7. PubMed ID: 23158209
[TBL] [Abstract][Full Text] [Related]
5. Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas.
Parker DC; Folpe AL; Bell J; Oliva E; Young RH; Cohen C; Amin MB
Am J Surg Pathol; 2003 Jan; 27(1):1-10. PubMed ID: 12502922
[TBL] [Abstract][Full Text] [Related]
6. Primary carcinoma of renal calyx.
Williams PA; Mai KT
Pathol Res Pract; 2013 Oct; 209(10):654-61. PubMed ID: 23999038
[TBL] [Abstract][Full Text] [Related]
7. Invasive high-grade urothelial carcinoma of the bladder, renal pelvis, ureter, and prostatic urethra arising in a background of urothelial carcinoma with an inverted growth pattern: a contemporary clinicopathological analysis of 91 cases.
Gutierrez CM; Alemozaffar M; Osunkoya AO
Hum Pathol; 2019 Oct; 92():18-24. PubMed ID: 31351154
[TBL] [Abstract][Full Text] [Related]
8. Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting.
Gupta R; Paner GP; Amin MB
Adv Anat Pathol; 2008 May; 15(3):127-39. PubMed ID: 18434765
[TBL] [Abstract][Full Text] [Related]
9. Carcinomas of the Renal Pelvis, Ureters, and Urinary Bladder Share a Carcinogenic Field as Revealed in Epidemiological Analysis of Tumor Registry Data.
Aragon-Ching JB; Nizam A; Henson DE
Clin Genitourin Cancer; 2019 Dec; 17(6):436-442. PubMed ID: 31445851
[TBL] [Abstract][Full Text] [Related]
10. Discrepancy between clinical and pathological T stages in upper urinary tract urothelial carcinoma: Analysis of the Hospital-Based Cancer Registry data in Japan.
Shiga M; Nagumo Y; Chihara I; Nitta S; Kojo K; Kimura T; Kandori S; Kojima T; Okuyama A; Higashi T; Nishiyama H
Int J Urol; 2021 Aug; 28(8):814-819. PubMed ID: 34013614
[TBL] [Abstract][Full Text] [Related]
11. Transitional cell carcinoma of the renal pelvis with choriocarcinomatous differentiation. Immunohistochemical and immunoelectron microscopic assessment of human chorionic gonadotropin production by transitional cell carcinoma of the urinary bladder.
Grammatico D; Grignon DJ; Eberwein P; Shepherd RR; Hearn SA; Walton JC
Cancer; 1993 Mar; 71(5):1835-41. PubMed ID: 8448745
[TBL] [Abstract][Full Text] [Related]
12. Renal pelvic urothelial carcinoma with divergent morphology.
Xiao GQ; Unger PD
Ann Diagn Pathol; 2010 Apr; 14(2):74-80. PubMed ID: 20227011
[TBL] [Abstract][Full Text] [Related]
13. [Markers of stem cells and their prognostic values for urothelial carcinomas of the urinary tract].
Osmanov YI; Kogan EA; Rapoport LM; Teodorovich OV; Gaibov JA
Urologiia; 2019 Jun; (2):40-49. PubMed ID: 31162900
[TBL] [Abstract][Full Text] [Related]
14. [Plasmacytoid urothelial carcinoma of the urinary bladder: a clinicopathologic study of 16 cases].
Zhang W; Jiang YX; Liu Y; Yu WJ; Zhao H; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):433-7. PubMed ID: 24246859
[TBL] [Abstract][Full Text] [Related]
15. Invasive micropapillary urothelial carcinoma of the bladder.
Lopez-Beltran A; Montironi R; Blanca A; Cheng L
Hum Pathol; 2010 Aug; 41(8):1159-64. PubMed ID: 20381120
[TBL] [Abstract][Full Text] [Related]
16. FGF7 Over Expression is an Independent Prognosticator in Patients with Urothelial Carcinoma of the Upper Urinary Tract and Bladder.
Fan EW; Li CC; Wu WJ; Huang CN; Li WM; Ke HL; Yeh HC; Wu TF; Liang PI; Ma LJ; Li CF
J Urol; 2015 Jul; 194(1):223-9. PubMed ID: 25623741
[TBL] [Abstract][Full Text] [Related]
17. [Synchronous manifestation of bladder inverted papilloma and transitional carcinoma of the renal pelvis].
Pereira Arias JG; Zabalza Estévez I; Maraña Fernández M; Escobal Tamayo V; Catalina AJ; Paz Romeral JL; Ibarluzea González JG; Bernuy Malfaz C
Arch Esp Urol; 1995 Dec; 48(10):1047-50. PubMed ID: 8588726
[TBL] [Abstract][Full Text] [Related]
18. Invasive urothelial carcinoma with chordoid features: a report of 12 distinct cases characterized by prominent myxoid stroma and cordlike epithelial architecture.
Cox RM; Schneider AG; Sangoi AR; Clingan WJ; Gokden N; McKenney JK
Am J Surg Pathol; 2009 Aug; 33(8):1213-9. PubMed ID: 19542871
[TBL] [Abstract][Full Text] [Related]
19. Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000.
David KA; Mallin K; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
Cancer; 2009 Apr; 115(7):1435-47. PubMed ID: 19215030
[TBL] [Abstract][Full Text] [Related]
20. Selective immunohistochemical markers to distinguish between metastatic high-grade urothelial carcinoma and primary poorly differentiated invasive squamous cell carcinoma of the lung.
Gruver AM; Amin MB; Luthringer DJ; Westfall D; Arora K; Farver CF; Osunkoya AO; McKenney JK; Hansel DE
Arch Pathol Lab Med; 2012 Nov; 136(11):1339-46. PubMed ID: 23106579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
